American Oncology Partners of Maryland

Bethesda, Maryland 20817

1 studies enrolling now · 9 studies all time

What they study most

Acute Lymphoblastic Leukemia, Adult B-Cell, Adult Solid Tumor, Advanced Cancer, Advanced Solid Tumor, Cancer Therapy-Related Diarrhea, Chemotherapy-related Diarrhea, Chronic Lymphocytic Leukemia, Colorectal Cancer (CRC), EGFR Exon 19 Deletion, EGFR L858R, Follicular Lymphoma, Metastatic Non Small Cell Lung Cancer

Studies at this site

• Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors — Recruiting now
• Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) — Running, not enrolling
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors — Running, not enrolling
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling
• The clonoSEQ® Watch Registry — Stopped early
• Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy — Completed
• Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma — Completed